ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,785,831	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	22.53%	22.53%	7.19%	5.54%	-
Enterprise Value	1,690,871	1,335,337	1,126,398	1,038,936	-
Last Close Price	36800.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	342.55	-
PS Ratio	52.91	43.22	17.97	16.33	195.31
PB Ratio	10.81	8.63	15.90	15.81	18.61
P/TBV Ratio	8.91	8.91	16.47	16.43	19.50
P/FCF Ratio	-	-	15.69	-
P/OCF Ratio	-	-	15.24	-
EV/Sales Ratio	50.62	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	321.37	-
EV/EBIT Ratio	-	-	1144.20	-
EV/FCF Ratio	-21.56	-	-	14.83	-
Debt / Equity Ratio	0.26	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	12.94	-
Debt / FCF Ratio	-	-	-	0.60	-
Asset Turnover	0.17	0.17	0.38	0.54	-
Quick Ratio	2.24	2.24	1.71	1.09	5.01
Current Ratio	2.28	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-46.01%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-18.93%	-18.93%	-0.95%	0.45%	-
Return on Capital (ROIC)	-22.56%	-22.56%	-1.43%	0.68%	-
Return on Capital Employed (ROCE)	-	-	-	0.80%	-
Earnings Yield	-3.11%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	-4.39%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-0.37%	-0.37%	-0.58%	-1.27%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.